Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Accenture plc executive Angie Y. Park, the company’s Chief Financial Officer, reported buying 1,100 Class A ordinary shares of Accenture on 12/05/2025. The shares were purchased from Accenture at a price of $268.535 per share through the Accenture Voluntary Equity Investment Program, which allows participants to acquire company stock directly from the issuer. Following this transaction, Park directly beneficially owns 9,793 Class A ordinary shares of Accenture.
Accenture plc reported an insider share purchase by its CEO-The Americas, John F. Walsh. On 12/05/2025, Walsh acquired 2,253 Class A ordinary shares of Accenture at a price of $268.535 per share. The shares were purchased directly from Accenture under the Accenture Voluntary Equity Investment Program, which allows eligible participants to buy company stock. Following this transaction, Walsh directly beneficially owns 24,675 Class A ordinary shares of Accenture.
Accenture plc's Chief Operating Officer, Catherine Kiernan Hogan, reported a purchase of company stock under an internal investment program. On 12/05/2025, she acquired 844 Class A ordinary shares of Accenture at a price of $268.535 per share through the Accenture Voluntary Equity Investment Program. Following this transaction, she beneficially owned 11,004 Class A ordinary shares directly, as well as 2,048 shares held indirectly in a family trust. This filing reflects an executive increasing her personal investment in Accenture through a company-sponsored equity program.
Accenture plc reported an insider share purchase by a senior executive. Chief Accounting Officer Melissa A. Burgum acquired 462 Class A ordinary shares of Accenture plc on 12/05/2025 at a price of $268.535 per share. The transaction was made directly with Accenture under the Accenture Voluntary Equity Investment Program, which allows executives to buy company stock. Following this purchase, Burgum beneficially owns 10,784 Class A ordinary shares held directly in her name.
Accenture plc reported that its Chair and CEO, Julie Spellman Sweet, who is also a director, acquired additional company stock. On 12/05/2025, she purchased 5,172 Class A ordinary shares of Accenture at a price of $268.535 per share through the Accenture Voluntary Equity Investment Program. Following this transaction, she beneficially owns 14,113 Class A ordinary shares, held directly.
Accenture plc executive Manish Sharma, Chief Strategy & Services Officer, reported buying additional company stock. On 12/05/2025, he acquired 1,502 Class A ordinary shares of Accenture at a price of $268.535 per share. The purchase was made directly from Accenture under the Accenture Voluntary Equity Investment Program, which allows eligible participants to invest in company shares. Following this transaction, Sharma beneficially owns 3,493 Class A ordinary shares in direct form. This filing reflects an increase in his personal equity stake rather than a sale or disposition of shares.
Accenture plc reported an insider share purchase by its General Counsel and Corporate Secretary. On 12/05/2025, the officer acquired 1,594 Class A ordinary shares of Accenture at a price of $268.535 per share under the Accenture Voluntary Equity Investment Program, which allows employees to buy company stock.
After this transaction, the officer directly beneficially owned 25,301 Class A ordinary shares. The filing indicates this was a straightforward purchase of non-derivative equity, with no derivative securities reported in connection with this transaction.
Accenture plc (ACN) reported insider activity by its Chief Accounting Officer, Melissa A. Burgum. On 11/14/2025, she acquired 37 Class A ordinary shares through a grant of restricted share units (RSUs) issued under anti-dilution provisions tied to a cash dividend, at a stated price of $0 per share. On the same date, 4 Class A ordinary shares were disposed of in a transaction reported with code "F" at a price of $246.62 per share. After these transactions, she beneficially owns 10,322 Class A ordinary shares, held directly.
Accenture plc director Paula A. Price reported a small equity grant in the form of restricted share units. On 11/14/2025 she received 7 Class A ordinary shares through a grant of restricted share units priced at $0 per share, reflecting an anti-dilution adjustment tied to Accenture plc's payment of a cash dividend under previously granted RSU awards. Following this transaction, she beneficially owns 7,368 Class A ordinary shares on a direct basis.
Accenture plc director Alan C. Jope reported a small equity award in the form of restricted share units. On 11/14/2025, he received 7 Class A ordinary shares at a price of $0 per share, reflecting a grant of RSUs made under anti-dilution provisions tied to Accenture's cash dividend. These provisions are designed so that previously granted RSU awards are adjusted when the company pays a dividend, helping keep the economic value of the prior awards consistent. Following this adjustment, Jope beneficially owns 1,985 Class A ordinary shares directly.